Clinical Trial Update: Preoperative Intratumor Dendritic Cells Injection Immunotherapy for Patients With Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update covers a Phase 1/2 study of preoperative intratumor dendritic cell immunotherapy for pancreatic cancer. The sponsor is Fukushima Medi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Dendritic cell vaccine (intratumor injection) (dendritic cell vaccine)

Snippet

Sponsor: Fukushima Medical University | Conditions: Pancreatic Cancer | Phase 1, Phase 2 | Status: UNKNOWN